SC
MDT icon

Sculptor Capital’s Medtronic MDT Stock Holding History

Sculptor Capital’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q4 		– Sell
-96,600
Closed -$5.98M – 803
2014
Q3 		$5.98M Sell
96,600
-47,100
-33% -$2.99M 0.02% 487
2014
Q2 		$9.16M Sell
143,700
-20,000
-12% -$1.21M 0.03% 415
2014
Q1 		$10.1M Sell
163,700
-13,700
-8% -$798K 0.03% 380
2013
Q4 		$10.2M Sell
177,400
-672,100
-79% -$38.1M 0.03% 452
2013
Q3 		$45.2M Buy
849,500
+409,500
+93% +$22M 0.13% 215
2013
Q2 		$22.6M Buy
+440,000
New +$21.7M 0.07% 307

Other funds holding MDT

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Sculptor Capital's MDT Position: Q4 2024 in Review

Sculptor Capital sold out of Medtronic (MDT) in Q4 2024, closing a stake of 113,500 shares — an estimated $10.2M sold.

Sculptor Capital first reported a position in MDT in Q4 2013 and held it in 7 quarters. The position peaked at $224M in Q2 2014. 2,123 funds tracked by Wall St. Rank hold MDT as of Q4 2024.

  • Sculptor Capital reported no remaining Medtronic position as of Q4 2024 after selling out during the quarter.
  • Sculptor Capital sold 113,500 Medtronic shares in Q4 2024, an estimated $10.2M.
  • Sculptor Capital first reported a position in Medtronic in Q4 2013 and held it in 7 quarters.
  • Sculptor Capital's Medtronic position peaked at $224M in Q2 2014.
  • 2,123 funds tracked by Wall St. Rank held Medtronic as of Q4 2024.

Based on Sculptor Capital's 13F filing for Q4 2024, filed 14 Feb 2025.